Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8083074rdf:typepubmed:Citationlld:pubmed
pubmed-article:8083074lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:8083074lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:8083074lifeskim:mentionsumls-concept:C0596790lld:lifeskim
pubmed-article:8083074lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:8083074lifeskim:mentionsumls-concept:C0681842lld:lifeskim
pubmed-article:8083074lifeskim:mentionsumls-concept:C0026777lld:lifeskim
pubmed-article:8083074lifeskim:mentionsumls-concept:C0220901lld:lifeskim
pubmed-article:8083074lifeskim:mentionsumls-concept:C0549193lld:lifeskim
pubmed-article:8083074lifeskim:mentionsumls-concept:C0439828lld:lifeskim
pubmed-article:8083074pubmed:issue5lld:pubmed
pubmed-article:8083074pubmed:dateCreated1994-10-11lld:pubmed
pubmed-article:8083074pubmed:abstractTextFrom January 1986 to October 1991, 90 patients with localized tumors were treated in a Phase I/II trial using low-dose 192Ir brachytherapy (IRT) plus interstitial 915 MHz microwave (MW) hyperthermia (IHT) and external beam radiotherapy (ERT). Tumors were classified as locally advanced primary (class 1: 27), recurrent (class 2: 40), metastatic (class 3: 10) and persistent (class 4: 13) lesions. The treatment sites included tumors of the head and neck (62), pelvis (26), and others (2). The mean cuboidal tumor volume was 63 cm3 (range: 8-288 cm3). Most recurrent and metastatic lesions (48) had received prior treatment including ERT.lld:pubmed
pubmed-article:8083074pubmed:languageenglld:pubmed
pubmed-article:8083074pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8083074pubmed:citationSubsetIMlld:pubmed
pubmed-article:8083074pubmed:statusMEDLINElld:pubmed
pubmed-article:8083074pubmed:monthJullld:pubmed
pubmed-article:8083074pubmed:issn0360-3016lld:pubmed
pubmed-article:8083074pubmed:authorpubmed-author:SauerRRlld:pubmed
pubmed-article:8083074pubmed:authorpubmed-author:BradyL WLWlld:pubmed
pubmed-article:8083074pubmed:authorpubmed-author:IroHHlld:pubmed
pubmed-article:8083074pubmed:authorpubmed-author:Seegenschmied...lld:pubmed
pubmed-article:8083074pubmed:authorpubmed-author:FietkauRRlld:pubmed
pubmed-article:8083074pubmed:authorpubmed-author:MartusPPlld:pubmed
pubmed-article:8083074pubmed:issnTypePrintlld:pubmed
pubmed-article:8083074pubmed:day30lld:pubmed
pubmed-article:8083074pubmed:volume29lld:pubmed
pubmed-article:8083074pubmed:ownerNLMlld:pubmed
pubmed-article:8083074pubmed:authorsCompleteYlld:pubmed
pubmed-article:8083074pubmed:pagination1049-63lld:pubmed
pubmed-article:8083074pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8083074pubmed:meshHeadingpubmed-meshheading:8083074-...lld:pubmed
pubmed-article:8083074pubmed:meshHeadingpubmed-meshheading:8083074-...lld:pubmed
pubmed-article:8083074pubmed:meshHeadingpubmed-meshheading:8083074-...lld:pubmed
pubmed-article:8083074pubmed:meshHeadingpubmed-meshheading:8083074-...lld:pubmed
pubmed-article:8083074pubmed:meshHeadingpubmed-meshheading:8083074-...lld:pubmed
pubmed-article:8083074pubmed:meshHeadingpubmed-meshheading:8083074-...lld:pubmed
pubmed-article:8083074pubmed:meshHeadingpubmed-meshheading:8083074-...lld:pubmed
pubmed-article:8083074pubmed:meshHeadingpubmed-meshheading:8083074-...lld:pubmed
pubmed-article:8083074pubmed:meshHeadingpubmed-meshheading:8083074-...lld:pubmed
pubmed-article:8083074pubmed:meshHeadingpubmed-meshheading:8083074-...lld:pubmed
pubmed-article:8083074pubmed:meshHeadingpubmed-meshheading:8083074-...lld:pubmed
pubmed-article:8083074pubmed:meshHeadingpubmed-meshheading:8083074-...lld:pubmed
pubmed-article:8083074pubmed:meshHeadingpubmed-meshheading:8083074-...lld:pubmed
pubmed-article:8083074pubmed:meshHeadingpubmed-meshheading:8083074-...lld:pubmed
pubmed-article:8083074pubmed:meshHeadingpubmed-meshheading:8083074-...lld:pubmed
pubmed-article:8083074pubmed:meshHeadingpubmed-meshheading:8083074-...lld:pubmed
pubmed-article:8083074pubmed:meshHeadingpubmed-meshheading:8083074-...lld:pubmed
pubmed-article:8083074pubmed:meshHeadingpubmed-meshheading:8083074-...lld:pubmed
pubmed-article:8083074pubmed:meshHeadingpubmed-meshheading:8083074-...lld:pubmed
pubmed-article:8083074pubmed:meshHeadingpubmed-meshheading:8083074-...lld:pubmed
pubmed-article:8083074pubmed:year1994lld:pubmed
pubmed-article:8083074pubmed:articleTitleMultivariate analysis of prognostic parameters using interstitial thermoradiotherapy (IHT-IRT): tumor and treatment variables predict outcome.lld:pubmed
pubmed-article:8083074pubmed:affiliationStrahlentherapeutische Klinik, Universität Erlangen-Nürnberg, Germany.lld:pubmed
pubmed-article:8083074pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8083074pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8083074pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:8083074pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed
pubmed-article:8083074pubmed:publicationTypeClinical Trial, Phase Illd:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8083074lld:pubmed